A Bakersfield, California, jury awarded $5.7 million on Thursday to a woman who alleged she was implanted with a defective TVT-Abbrevo pelvic mesh sling made by Ethicon, a subsidiary of Johnson & Johnson (J&J). It was the first trial centered on the device.
The TVT-Abbrevo device is intended for the treatment of urinary incontinence caused by sudden movements. The plaintiff in the case, who had the device implanted in 2011, alleged that her TVT-Abbrevo caused her pain and continued urinary incontinence, according to The National Law Journal (The Journal). More First TVT-Abbrevo Trial Ends in $5.7 Verdict for the Plaintiff